Open AccessHow should one read “real-life data” regarding NOAC’s? “The case with rivaroxaban”
Author(s) -
Özgür Aslan
Publication year - 2017
Publication title -
turk kardiyoloji dernegi arsivi-archives of the turkish society of cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.2
H-Index - 24
ISSN - 1016-5169
DOI - 10.5543/tkda.2017.33903
Subject(s) - rivaroxaban , randomized controlled trial , medicine , protocol (science) , clinical trial , data collection , vitamin k antagonist , health care , real world data , intensive care medicine , medical physics , computer science , alternative medicine , data science , surgery , statistics , mathematics , pathology , warfarin , cardiology , atrial fibrillation , economics , economic growth
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom